Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QGLY - Funny Name Great Product. -- Ignore unavailable to you. Want to Upgrade?

To: drakes353 who wrote (8674)	12/16/1998 3:35:00 PM
From: Cosmo Kramer	Read Replies (1) \| Respond to of 8960

I never said Walgreen's was the channel, but the product that goes on ANY shelf is filling a channel.

To: drakes353 who wrote (8674)	12/16/1998 3:38:00 PM
From: Will Preska	Respond to of 8960

Drakes, You said that BodyMate was untested/unproven. In the new "News" release, it's stated that BodyMate was in fact tested in trials. It'd be interesting to learn more about these "trials", wouldn't it? - Will

To: drakes353 who wrote (8674)	12/16/1998 3:42:00 PM
From: Will Preska	Read Replies (1) \| Respond to of 8960

What do you mean when you say, "last I checked Walgreen's wasn't the channel" From the opening sentence of today's "news": DOYLESTOWN, Pa., Dec. 16 /PRNewswire/ -- The Quigley Corporation (Nasdaq: QGLY - news) announced today they will begin initial marketing of BODYMATE™, a unique weight management lozenge, and KIDS-EEZE™, a bubble-gum version of COLD-EEZE®, the only zinc gluconate glycine (ZIGG™) cold formulation, in January 1999 with Walgreen's. - Will